<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Eli Lilly Begins Phase III Clinical Trial for Coronavirus
Image Overlay - Eli Lilly Begins Phase III Clinical Trial for Coronavirus

Eli Lilly Begins Phase III Clinical Trial for Coronavirus

June 24, 2020

Eli Lilly Begins Phase III Clinical Trial for Coronavirus

The company has begun phase III clinical trials for Olumiant, which is an approved treatment for rheumatoid arthritis. The company will enroll 400 patients in the U.S., Europe, and Latin America in the trial for the potential coronavirus treatment. With depots across Latin America and Europe and headquarters in the U.S., Yourway is equipped to service global clinical trials.

Back to Index
Media

Upcoming Events

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?